Found: 69
Select item for more details and to access through your institution.
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 18, doi. 10.1111/dom.14206
- By:
- Publication type:
- Article
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2055, doi. 10.1111/dom.14122
- By:
- Publication type:
- Article
Endoscopic Coblation versus Cold Curettage Adenoidectomy.
- Published in:
- QJM: An International Journal of Medicine, 2021, v. 114, p. i111, doi. 10.1093/qjmed/hcab094.006
- By:
- Publication type:
- Article
Predicting the maximum sunspot number and the associated geomagnetic activity indices aa and Ap for solar cycle 25.
- Published in:
- Astrophysics & Space Science, 2021, v. 366, n. 5, p. 1, doi. 10.1007/s10509-021-03953-3
- By:
- Publication type:
- Article
High frequency spectral features of galactic cosmic rays at different rigidities during the ascending and maximum phases of the solar cycle 24.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Silicone rubber‐nanoceramic composites for 5G antenna substrates.
- Published in:
- Journal of Engineering, 2023, v. 2023, n. 9, p. 1, doi. 10.1049/tje2.12312
- By:
- Publication type:
- Article
Testosterone Deficiency and Testosterone Treatment in Older Men.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
- Published in:
- Vascular Health & Risk Management, 2021, v. 17, p. 497, doi. 10.2147/VHRM.S309714
- By:
- Publication type:
- Article
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
298-OR: Lipid Pattern in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison with an Untreated Control Group: Update of Real-World Registry Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-298-OR
- By:
- Publication type:
- Article
240-OR: Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-240-OR
- By:
- Publication type:
- Article
238-OR: Treatment with Testosterone Undecanoate Injections (TU) Up to 12 Years Improves Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data with 3,149 Patient-Years.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-238-OR
- By:
- Publication type:
- Article
1220-P: Treatment with Testosterone Undecanoate Injections (TU) Results in Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Urological Practice.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1220-P
- By:
- Publication type:
- Article
758-P: Treatment with Testosterone Undecanoate Injections (TU) Improves Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus: Update of Real-World Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-758-P
- By:
- Publication type:
- Article
136-OR: Lipid Profile in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: Update of Real-World Registry Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-136-OR
- By:
- Publication type:
- Article
401-P: Mortality, Major Adverse Cardiovascular Events (MACDE), and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): 11-Year Real-World Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-401-P
- By:
- Publication type:
- Article
2004-P: Treatment with Testosterone Undecanoate Injections (TU) Results in Marked Weight Loss That Is Maintained Long Term in Men with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data from a Urological Practice.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2004-P
- By:
- Publication type:
- Article
1075-P: Long-Term Treatment with Testosterone Undecanoate Injections (TU) Improves Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data with 2,928 Patient-Years.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1075-P
- By:
- Publication type:
- Article
1057-P: Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1057-P
- By:
- Publication type:
- Article
1058-P: Effects of Treatment with Testosterone Undecanoate Injections (TU) on Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus (T2DM) Compared with an Untreated Control Group: Real-World Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1058-P
- By:
- Publication type:
- Article
178-OR: Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-178-OR
- By:
- Publication type:
- Article
1137-P: Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1137-P
- By:
- Publication type:
- Article
1124-P: Beneficial Changes in Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Registry.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1124-P
- By:
- Publication type:
- Article
1123-P: Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1123-P
- By:
- Publication type:
- Article
2084-P: Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2084-P
- By:
- Publication type:
- Article
The emancipation of testosterone from niche hormone to multi‑system player.
- Published in:
- Asian Journal of Andrology, 2015, v. 17, n. 1, p. 58, doi. 10.4103/1008-682X.137684
- By:
- Publication type:
- Article
More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
- Published in:
- Asian Journal of Andrology, 2007, v. 9, n. 3, p. 291, doi. 10.1111/j.1745-7262.2007.00275.x
- By:
- Publication type:
- Article
Recent insights into androgen action on the anatomical and physiological substrate of penile erection.
- Published in:
- Asian Journal of Andrology, 2006, v. 8, n. 1, p. 3, doi. 10.1111/j.1745-7262.2006.00105.x
- By:
- Publication type:
- Article
High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.
- Published in:
- European Journal of Endocrinology, 2022, v. 186, n. 3, p. 319, doi. 10.1530/EJE-21-0545
- By:
- Publication type:
- Article
Testosterone supplementation and body composition: results from a meta-analysis study.
- Published in:
- European Journal of Endocrinology, 2016, v. 174, n. 3, p. R99, doi. 10.1530/EJE-15-0262
- By:
- Publication type:
- Article
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.
- Published in:
- European Journal of Endocrinology, 2013, v. 168, n. 6, p. 829, doi. 10.1530/EJE-12-0955
- By:
- Publication type:
- Article
Onset of effects of testosterone treatment and time span until maximum effects are achieved.
- Published in:
- European Journal of Endocrinology, 2011, v. 165, n. 5, p. 675, doi. 10.1530/EJE-11-0221
- By:
- Publication type:
- Article
Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2050313X18823454
- By:
- Publication type:
- Article
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.
- Published in:
- Obesity (19307381), 2013, v. 21, n. 10, p. 1975, doi. 10.1002/oby.20407
- By:
- Publication type:
- Article
Effect of additives on sintering of α-cristobalite.
- Published in:
- Journal of Materials Science, 2014, v. 49, n. 12, p. 4133, doi. 10.1007/s10853-014-8108-4
- By:
- Publication type:
- Article
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.
- Published in:
- Korean Journal of Urology, 2015, v. 56, n. 4, p. 310, doi. 10.4111/kju.2015.56.4.310
- By:
- Publication type:
- Article
Clinically occult prostate cancer cases may distort the effect of testosterone replacement therapy on risk of PCa.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 10, p. 2091, doi. 10.1007/s00345-018-02621-6
- By:
- Publication type:
- Article
Lower urinary-tract symptoms and testosterone in elderly men.
- Published in:
- World Journal of Urology, 2008, v. 26, n. 4, p. 359, doi. 10.1007/s00345-008-0284-x
- By:
- Publication type:
- Article
Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido<sup>®</sup>).
- Published in:
- World Journal of Urology, 2006, v. 24, n. 6, p. 639, doi. 10.1007/s00345-006-0120-0
- By:
- Publication type:
- Article
Attitudes toward male fertility control: results of a multinational survey on four continents.
- Published in:
- Human Reproduction, 2005, v. 20, n. 2, p. 549, doi. 10.1093/humrep/deh574
- By:
- Publication type:
- Article
Modeling of Viscosity and Thermal Expansion of Bioactive Glasses.
- Published in:
- ISRN Ceramics, 2012, p. 1, doi. 10.5402/2012/816902
- By:
- Publication type:
- Article
Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.
- Published in:
- BJU International, 2007, v. 99, n. 5, p. 988, doi. 10.1111/j.1464-410X.2007.06756.x
- By:
- Publication type:
- Article
The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics.
- Published in:
- Health & Quality of Life Outcomes, 2003, v. 1, p. 77, doi. 10.1186/1477-7525-1-77
- By:
- Publication type:
- Article
The Aging Males' Symptoms (AMS) scale: Update and compilation of international versions.
- Published in:
- Health & Quality of Life Outcomes, 2003, v. 1, p. 15, doi. 10.1186/1477-7525-1-15
- By:
- Publication type:
- Article
Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2012, v. 28, p. 52, doi. 10.1002/dmrr.2354
- By:
- Publication type:
- Article
Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.
- Published in:
- Investigative & Clinical Urology, 2018, v. 59, n. 6, p. 399, doi. 10.4111/icu.2018.59.6.399
- By:
- Publication type:
- Article
Arif Adimoelja - in honour of his 80th birthday.
- Published in:
- Andrologia, 2012, v. 44, n. 4, p. 289, doi. 10.1111/j.1439-0272.2012.01325.x
- By:
- Publication type:
- Article
Effects of Long-Term Testosterone Therapy on Patients with "Diabesity": Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes.
- Published in:
- International Journal of Endocrinology, 2014, p. 1, doi. 10.1155/2014/683515
- By:
- Publication type:
- Article
Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years.
- Published in:
- International Journal of Endocrinology, 2014, p. 1, doi. 10.1155/2014/496948
- By:
- Publication type:
- Article